SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-003693
Filing Date
2021-08-16
Accepted
2021-08-16 15:12:50
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 30, 2021 cannarx_i10q-063021.htm   iXBRL 10-Q 848124
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES cannarx_10q-ex3101.htm EX-31.1 11695
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES cannarx_10q-ex3102.htm EX-31.2 11755
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO cannarx_10q-ex3200.htm EX-32 5332
  Complete submission text file 0001683168-21-003693.txt   4347309

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cpmd-20210630.xsd EX-101.SCH 41074
6 XBRL CALCULATION FILE cpmd-20210630_cal.xml EX-101.CAL 51464
7 XBRL DEFINITION FILE cpmd-20210630_def.xml EX-101.DEF 161022
8 XBRL LABEL FILE cpmd-20210630_lab.xml EX-101.LAB 295335
9 XBRL PRESENTATION FILE cpmd-20210630_pre.xml EX-101.PRE 243431
10 EXTRACTED XBRL INSTANCE DOCUMENT cannarx_i10q-063021_htm.xml XML 568198
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 211177218
SIC: 2834 Pharmaceutical Preparations